Summit Therapeutics Inc. Quarterly Unrecognized Tax Benefits in USD from Q4 2020 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
Summit Therapeutics Inc. quarterly Unrecognized Tax Benefits history and growth rate from Q4 2020 to Q4 2023.
  • Summit Therapeutics Inc. Unrecognized Tax Benefits for the quarter ending December 31, 2023 was $1.06M.
Unrecognized Tax Benefits, Quarterly (USD)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $1.06M +$1.06M Dec 31, 2023 10-K 2024-02-20
Q4 2022 $0 $0 Dec 31, 2022 10-K 2024-02-20
Q4 2021 $0 $0 Dec 31, 2021 10-K 2024-02-20
Q4 2020 $0 Dec 31, 2020 10-K/A 2022-12-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.